Abdelsalam, S.S.; Zahid, M.A.; Ghanem, S.K.; Khan, A.; Parray, A.; Agouni, A.
Sestrin2 Suppression Promotes Endothelial–Mesenchymal Transition and Exacerbates Methylglyoxal-Induced Endothelial Dysfunction. Int. J. Mol. Sci. 2024, 25, 13463.
https://doi.org/10.3390/ijms252413463
AMA Style
Abdelsalam SS, Zahid MA, Ghanem SK, Khan A, Parray A, Agouni A.
Sestrin2 Suppression Promotes Endothelial–Mesenchymal Transition and Exacerbates Methylglyoxal-Induced Endothelial Dysfunction. International Journal of Molecular Sciences. 2024; 25(24):13463.
https://doi.org/10.3390/ijms252413463
Chicago/Turabian Style
Abdelsalam, Shahenda Salah, Muhammad Ammar Zahid, Sarah Khalaf Ghanem, Abbas Khan, Aijaz Parray, and Abdelali Agouni.
2024. "Sestrin2 Suppression Promotes Endothelial–Mesenchymal Transition and Exacerbates Methylglyoxal-Induced Endothelial Dysfunction" International Journal of Molecular Sciences 25, no. 24: 13463.
https://doi.org/10.3390/ijms252413463
APA Style
Abdelsalam, S. S., Zahid, M. A., Ghanem, S. K., Khan, A., Parray, A., & Agouni, A.
(2024). Sestrin2 Suppression Promotes Endothelial–Mesenchymal Transition and Exacerbates Methylglyoxal-Induced Endothelial Dysfunction. International Journal of Molecular Sciences, 25(24), 13463.
https://doi.org/10.3390/ijms252413463
